The Chemours Company
General ticker "CC" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $2.2B (TTM average)
The Chemours Company follows the US Stock Market performance with the rate: 37.5%.
Estimated limits based on current volatility of 3.1%: low 15.09$, high 16.07$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-11-14, amount 0.09$ (Y2.31%)
- Total employees count: 6000 as of 2024
- North America accounted for 44.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Pandemic risks, Environmental liabilities, Regulatory and compliance, Geopolitical risks, Market competition
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [9.80$, 20.47$]
- 2025-12-31 to 2026-12-31 estimated range: [9.53$, 19.54$]
Financial Metrics affecting the CC estimates:
- Positive: with PPE of 14.3 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of -24.48 <= 0.04
- Positive: 7.54 < Operating profit margin, % of 7.66
- Negative: Industry operating cash flow per share per price (median), % of 4.99 <= 5.42
- Negative: Shareholder equity ratio, % of 8.04 <= 19.35
- Negative: Investing cash flow per share per price, % of -13.65 <= -4.41
- Negative: Return on assets ratio (scaled to [-100,100]) of 1.13 <= 1.77
- Negative: Industry operating profit margin (median), % of 5.52 <= 9.53
Short-term CC quotes
Long-term CC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $6,831.00MM | $6,078.00MM | $5,782.00MM |
| Operating Expenses | $6,045.00MM | $6,201.00MM | $5,339.00MM |
| Operating Income | $786.00MM | $-123.00MM | $443.00MM |
| Non-Operating Income | $-45.00MM | $-195.00MM | $-316.00MM |
| Interest Expense | $163.00MM | $208.00MM | $264.00MM |
| R&D Expense | $118.00MM | $108.00MM | $109.00MM |
| Income(Loss) | $741.00MM | $-318.00MM | $127.00MM |
| Taxes | $163.00MM | $-81.00MM | $41.00MM |
| Profit(Loss)* | $578.00MM | $-238.00MM | $86.00MM |
| Stockholders Equity | $1,107.00MM | $737.00MM | $604.00MM |
| Inventory | $1,404.00MM | $1,352.00MM | $1,472.00MM |
| Assets | $7,640.00MM | $8,251.00MM | $7,515.00MM |
| Operating Cash Flow | $755.00MM | $556.00MM | $-633.00MM |
| Capital expenditure | $307.00MM | $370.00MM | $360.00MM |
| Investing Cash Flow | $-284.00MM | $-229.00MM | $-353.00MM |
| Financing Cash Flow | $-686.00MM | $172.00MM | $-36.00MM |
| Earnings Per Share** | $3.72 | $-1.60 | $0.58 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.